# Meta AML Explorer (Shiny)

Interactive Shiny app for exploring acute myeloid leukemia (AML) mutational data. Two data sources:

- **Benard et al. (2021)** — Data from Benard et al. (2021) *Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia*, Nature Communications (~2,800 patients, 12 cohorts).
- **Meta AML4** — Merged cohort of TCGA LAML (~200), BeatAML2 (805), AML-SG (1,540), and UK-NCRI (2,113) patients (~4,660 combined). Same analyses and filters.

Access the Shiny app at [https://brooks-benard.shinyapps.io/MetaAML_Shiny/](https://brooks-benard.shinyapps.io/MetaAML_Shiny/).

## Citation

Benard, B.A., Leak, L.B., Azizi, A. et al. Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia. *Nat Commun* 12, 7244 (2021). https://doi.org/10.1038/s41467-021-27472-5
